Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - TOTAL LIABILITIES
Total Liabilities ALLO - Allogene Therapeutics, Inc.
131 M
LAST VALUE
3.37%
2 YEAR CAGR
13.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR